BRIEF—Neuraxpharm builds base in South America

Central nervous system (CNS) specialist Neuraxpharm has established outposts in Brazil and Mexico, as part of its strategy to globalize its operations outside Europe.

Neuraxpharm’s move is facilitated by the purchase of local firm Libber Pharma, enabling distribution and commercialization in the region.

Last year the firm  bought Sanofi’s portfolio of CNS products, including one neuroleptic and three antipsychotic products, in Brazil.

Chief executive Jörg-Thomas Dierks said: “Our direct presence in Brazil and Mexico will provide us with a platform from which to distribute Neuraxpharm products to healthcare professionals and patients in the two largest pharmaceutical markets in Latin America.”